197 related articles for article (PubMed ID: 12410780)
1. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
Lintzeris N; Bell J; Bammer G; Jolley DJ; Rushworth L
Addiction; 2002 Nov; 97(11):1395-404. PubMed ID: 12410780
[TBL] [Abstract][Full Text] [Related]
2. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
[TBL] [Abstract][Full Text] [Related]
3. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
4. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.
Gibson AE; Doran CM; Bell JR; Ryan A; Lintzeris N
Med J Aust; 2003 Jul; 179(1):38-42. PubMed ID: 12831383
[TBL] [Abstract][Full Text] [Related]
5. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
[TBL] [Abstract][Full Text] [Related]
6. Three methods of opioid detoxification in a primary care setting. A randomized trial.
O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone shortened opioid detoxification with buprenorphine.
Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
[TBL] [Abstract][Full Text] [Related]
8. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
Ziedonis DM; Amass L; Steinberg M; Woody G; Krejci J; Annon JJ; Cohen AJ; Waite-O'Brien N; Stine SM; McCarty D; Reid MS; Brown LS; Maslansky R; Winhusen T; Babcock D; Brigham G; Muir J; Orr D; Buchan BJ; Horton T; Ling W
Drug Alcohol Depend; 2009 Jan; 99(1-3):28-36. PubMed ID: 18805656
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine for acute heroin detoxification: diffusion of research into practice.
Kovas AE; McFarland BH; McCarty DJ; Boverman JF; Thayer JA
J Subst Abuse Treat; 2007 Mar; 32(2):199-206. PubMed ID: 17306728
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
Dunn KE; Tompkins DA; Bigelow GE; Strain EC
JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
[TBL] [Abstract][Full Text] [Related]
11. Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison.
Kasvikis Y; Bradley B; Gossop M; Griffiths P; Marks I
Int J Addict; 1990 Oct; 25(10):1169-78. PubMed ID: 2090621
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine dosing regime in the management of out-patient heroin withdrawal.
Lintzeris N
Drug Alcohol Rev; 2002 Mar; 21(1):39-45. PubMed ID: 12189003
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
16. Heroin anticraving medications: a systematic review.
Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
[TBL] [Abstract][Full Text] [Related]
17. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine in opiate withdrawal: a comparison with clonidine.
Nigam AK; Ray R; Tripathi BM
J Subst Abuse Treat; 1993; 10(4):391-4. PubMed ID: 8257551
[TBL] [Abstract][Full Text] [Related]
19. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Negus SS
J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine for the management of opioid withdrawal.
Gowing L; Ali R; White J
Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
